We're unable to sign you in at this time. Please try again in a few minutes.
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Other Articles |


JAMA. 1950;142(5):342-343. doi:10.1001/jama.1950.02910230044012.
Text Size: A A A
Published online


Behnisch and his co-workers1 at the laboratories of Farbenfabriken Bayer at the Elberfeld Works, Germany, have developed, in cooperation with Domagk, a group of chemical substances, thiosemicarbazones, which possess chemotherapeutic effect against tuberculosis. The activity of these products, according to these investigators, is not dependent on the sulfonamide or sulfone groups, nor on the thiazole or thiodiazole rings, but on an open chainlike arrangement of the nitrogen and sulfur atoms, such as is present in the thiosemicarbazones when suitably substituted. The most active of these substances is 4-aminoacetylbenzaldehyde thiosemicarbazone, designated as conteben or TbI/698. Domagk2 states that this substance has an effect on the tubercle bacillus in vitro and in vivo. He demonstrated in experimental tuberculosis in guinea pigs that the effect is much like that of para-amino-salicylic acid. Although the mode of action of the drug has not been established, Domagk believes that it exerts a direct


Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

First Page Preview

View Large
First page PDF preview




Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.


Some tools below are only available to our subscribers or users with an online account.

0 Citations

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

Related Content

Customize your page view by dragging & repositioning the boxes below.

See Also...